Bosh sahifaMNKD • NASDAQ
add
MannKind Corp
Yopilish kursi
4,91 $
Kunlik diapazon
4,88 $ - 5,02 $
Yillik diapazon
4,15 $ - 7,62 $
Bozor kapitalizatsiyasi
1,51 mlrd USD
Oʻrtacha hajm
1,95 mln
Narx/foyda
51,19
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 76,78 mln | 31,30% |
Joriy xarajat | 35,11 mln | 17,93% |
Sof foyda | 7,42 mln | 429,76% |
Sof foyda marjasi | 9,67 | 302,92% |
Har bir ulushga tushum | — | — |
EBITDA | 24,22 mln | 104,25% |
Amaldagi soliq stavkasi | 12,11% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 203,56 mln | -32,60% |
Jami aktivlari | 393,84 mln | -17,12% |
Jami passivlari | 472,66 mln | -34,48% |
Umumiy kapital | -78,82 mln | — |
Tarqatilgan aksiyalar | 303,59 mln | — |
Narxi/balansdagi bahosi | -18,88 | — |
Aktivlardan daromad | 12,86% | — |
Kapitaldan daromad | 52,03% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 7,42 mln | 429,76% |
Operatsiyalardan naqd pul | 22,64 mln | 4,46% |
Sarmoyadan naqd pul | 48,22 mln | 710,82% |
Moliyadan naqd pul | -86,90 mln | -161,33% |
Naqd pulning sof oʻzgarishi | -16,03 mln | -110,31% |
Boʻsh pul | 30,14 mln | 94,30% |
Haqida
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Tashkil etilgan
fev 1991
Sayt
Xodimlar soni
405
